Tivicay is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Dolutegravir Sodium.
Product ID | 49702-228_12d2a862-eacf-4ebe-a7da-4ed20faef568 |
NDC | 49702-228 |
Product Type | Human Prescription Drug |
Proprietary Name | Tivicay |
Generic Name | Dolutegravir Sodium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2013-08-13 |
Marketing Category | NDA / NDA |
Application Number | NDA204790 |
Labeler Name | ViiV Healthcare Company |
Substance Name | DOLUTEGRAVIR SODIUM |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-08-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-13 |
Ingredient | Strength |
---|---|
DOLUTEGRAVIR SODIUM | 50 mg/1 |
SPL SET ID: | 63df5af3-b8ac-4e76-9830-2dbb340af922 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
49702-226 | Tivicay | dolutegravir sodium |
49702-227 | Tivicay | dolutegravir sodium |
49702-228 | Tivicay | dolutegravir sodium |
50090-1355 | Tivicay | dolutegravir sodium |
53808-1130 | Tivicay | dolutegravir sodium |
67296-1818 | Tivicay | dolutegravir sodium |
70518-1487 | Tivicay | dolutegravir sodium |
49702-255 | Tivicay PD | dolutegravir sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TIVICAY 77509933 not registered Dead/Abandoned |
GLAXOSMITHKLINE LLC 2008-06-27 |
TIVICAY 77063119 3618019 Live/Registered |
VIIV HEALTHCARE COMPANY 2006-12-13 |